Publication | Closed Access

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

InflammationToll-like ReceptorsCancer ImmunosurveillanceImmune Cell DevelopmentInnate Immune SystemImmunologyTumor ImmunityImmune RegulationT Cell ImmunityCd4 T Cell ResponsesInnate ImmunityToll-like Receptor 4–DependentImmune SystemMedicineRadiation Oncology